A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

720

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Triple Negative Breast Cancer

Interventions

DRUG

Paclitaxel + Carboplatin

Platinum based chemotherapy against the standard taxane based chemotherapy in the neo- adjuvant setting

DRUG

Paclitaxel only

Trial Locations (1)

Tata memorial Centre, Mumbai

All Listed Sponsors

lead

Tata Memorial Hospital

OTHER_GOV